If you have tried several antidepressants and still feel stuck, you have probably heard of Spravato. It is one of the few treatments designed specifically for people whose depression has not responded to standard medication.
This guide explains what Spravato is, who it is for, what treatment looks like, and what to expect, so you can walk into a consultation with clear information.
What Is Spravato?
Spravato is the brand name for esketamine, a nasal spray related to ketamine. The FDA approved it in 2019 for treatment-resistant depression, and its approvals have since expanded:
- 2019: Treatment-resistant depression in adults, used together with an oral antidepressant.
- 2020: Depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior.
- 2025: Treatment-resistant depression as a standalone treatment, without a separate oral antidepressant.
Because of these approvals, Spravato has a clearer insurance pathway than IV ketamine, which is used off-label.
How Does Spravato Work?
Most antidepressants act on serotonin. Spravato works on the glutamate system by blocking NMDA receptors, which triggers a burst of activity that supports the growth of new connections between neurons in mood-regulating areas of the brain.
This is why Spravato can help people who did not respond to serotonin-based medications, and why some patients notice changes within hours to days instead of weeks.
Who Is Spravato For?
Spravato is designed for adults with treatment-resistant depression, generally defined as an inadequate response to at least two antidepressants given at adequate doses for adequate time. It is also approved for adults with major depressive disorder who have acute suicidal ideation or behavior.
Your psychiatrist will also consider your medical history. Spravato is not appropriate for people with certain conditions, including aneurysmal vascular disease, arteriovenous malformation, or a history of intracerebral hemorrhage. Uncontrolled high blood pressure, a history of substance use, and pregnancy all require careful evaluation.
Spravato is FDA-approved for treatment-resistant depression in adults and for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior.
Adults who have not responded adequately to at least two antidepressants, or adults with major depressive disorder and acute suicidal ideation or behavior. A psychiatrist also reviews your medical history for safety.
Spravato acts on the glutamate system rather than serotonin, which supports new connections between neurons. This is why it can help patients who did not respond to serotonin-based medications.
People with aneurysmal vascular disease, arteriovenous malformation, or a history of intracerebral hemorrhage should not use it. Uncontrolled high blood pressure, substance use history, and pregnancy require careful evaluation.
What Treatment Looks Like
Spravato is not a take-home medication. It must be given in a certified healthcare setting.
Before your session. Follow your clinic’s instructions about food and drink beforehand. The label advises avoiding food for at least two hours and liquids for at least 30 minutes before a dose, because nausea can occur.
Blood pressure check. Your blood pressure is measured before dosing, since Spravato can raise it temporarily.
Self-administration. You use the nasal spray yourself, under supervision, at a dose of 56 mg or 84 mg set by your psychiatrist.
Observation. You stay at the clinic for at least two hours while the care team monitors you. You may feel dissociated, dizzy, or sleepy during this time. These effects usually fade within a few hours.
Going home. You cannot drive that day. The label advises waiting until the next day after a restful night of sleep before driving or operating machinery, so arrange a ride.
Schedule. Treatment is typically twice a week for the first four weeks, weekly for weeks five through eight, and then every one to two weeks depending on your response.
Plan on at least two hours at the clinic, because you are monitored after the dose.
No. You cannot drive that day. The label advises waiting until the next day after a restful night of sleep.
Typically twice weekly for the first four weeks, weekly for weeks five through eight, then every one to two weeks based on your response.
Most major plans cover it for eligible patients, usually with prior authorization. NeuPath verifies benefits and handles authorization before treatment.
What Does the Research Show?
In clinical trials, patients who received esketamine along with a new oral antidepressant improved more than patients who received a placebo spray with a new oral antidepressant. In a pivotal maintenance study, continuing esketamine reduced the risk of relapse by about 51 percent among patients in stable remission and about 70 percent among patients with a stable response, compared with switching to placebo.
Results vary by person, and Spravato does not work for everyone. A realistic expectation is that many patients with treatment-resistant depression benefit, and that ongoing treatment helps keep that benefit in place.
Side Effects
The most common side effects happen during or shortly after a session and usually resolve the same day:
- Dissociation or a floaty, detached feeling
- Dizziness or vertigo
- Nausea
- Drowsiness
- Temporary increase in blood pressure
- Anxiety during the session
The supervised setting and two-hour observation period exist to manage these safely.
Is Spravato Covered by Insurance?
Spravato is covered by most major insurance plans for patients who meet clinical criteria, usually with prior authorization. NeuPath verifies your benefits and handles authorization before your first session, and explains your expected copay or coinsurance upfront.
Spravato, TMS, or IV Ketamine?
All three are options for treatment-resistant depression, and they work differently. TMS is medication-free and requires no recovery time. IV ketamine allows more flexible dosing but is generally paid out of pocket. Spravato is FDA-approved and typically covered. A psychiatrist can help you choose, and in some cases combine them.
| Spravato at NeuPath Mind Wellness |
|---|
| NeuPath offers Spravato at our Delray Beach, Boca Raton, and Boynton Beach locations, alongside TMS, IV ketamine, GeneSight testing, and medication management. If one approach is not enough, your plan can change without starting over somewhere new. |
| Book a free consultation to find out whether Spravato is right for you. |


